Free Newsletter
Harvard officials to probe psychiatrists’ drug payments
Officials at Mass General and Harvard Medical School have opened an investigation into the financial relationship between three prominent psychiatrists and the drug companies they did key research work for after Senator Charles Grassley accused them of hiding potential conflicts of interest. According to a report in the New York Times, the three had revealed that drug companies had paid them several hundred thousand dollars over a period of seven years. But when pressed, the figure grew to $1 million to $1.6 million for each. The three men involved are Joseph Biederman, Timothy E. Wilens, and Thomas Spencer, and the report notes that the full amount they were paid may be even higher than what the three are now admitting.
The Times' article highlights the prominent role that the three psychiatrists played in promoting an explosion of prescriptions for ADHD drugs. An NIH official says any violation of policy will not be tolerated.
- read the story in the Boston Globe
- check out the report in the New York Times
Related Articles:
Harvard docs fail to report drug money
Psychiatrists getting largest pharma gifts
Med schools don't police pharma gifts, report says
AAMC: Ban pharma gifts at med schools
Arms twisted, pharma promises disclosure
Comments
Post new comment
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession




